China has approved the emergency use of Sinovac-manufactured COVID-19 vaccine, CoronaVac, for children from three to 17 years old. Chinese health authorities found that the Coronavac is “at least 98.9 percent effective in producing antibodies, a higher efficacy than in population over 18 years old.”, according to its Phase III clinical trial data. The Chinese …

The post China approves Sinovac for kids aged 5-17 appeared first on The Filipino Times.